Search results
Author(s):
Marat Fudim
,
David Duncker
Added:
5 days ago
In this episode of Arrhythmia Academy's Journal Club, Dr David Duncker (Hannover Heart Rhythm Center, DE) is joined by Dr Marat Fudim (Duke University, US) to examine the critical early-risk period following heart failure diagnosis and the emerging role of wearable cardioverter defibrillators in sudden cardiac death prevention.The discussion centres on findings from the SCD-PROTECT study, a 19…
View more
Author(s):
Added:
3 months ago
AHA Scientific Sessions 2025 - Dr Sarah Cuddy (Brigham and Women's Hospital, US) joins us to discuss the role of non-disease modifying treatments including SGLT2 inhibitors, mineralocorticoid receptor antagonists, GLP-1 receptor agonists, and implantable hemodynamic monitors in cardiac amyloidosis, and what this means for managing heart failure in this unique patient population.Interview…
View more
Author(s):
Vasvi Singh
Added:
5 months ago
Navigate the diagnostic complexities of cardiac amyloidosis through expert multimodality imaging techniques with Dr Vasvi Singh.This comprehensive presentation, part of the Cardiomyopathies track, addresses the critical role of advanced imaging in diagnosing cardiac amyloidosis. Dr Singh explores the nuanced differences between SPECT and SPECT-CT imaging capabilities, providing practical insights…
View more
Author(s):
Added:
5 months ago
Discover the rapidly evolving therapeutic options transforming outcomes for cardiac amyloidosis patients with Dr Sarah Cuddy.This comprehensive presentation, part of the Cardiomyopathies track, explores the dramatic advances in both TTR and AL amyloidosis treatment over the past decade. Dr Cuddy examines how modern therapeutic approaches have fundamentally shifted survival curves, particularly…
View more
Author(s):
Narra Lavanya
,
Abraham Oomman
Added:
10 months ago
Added:
9 months ago
New Innovations to Address Sudden Cardiac Arrest
Author(s):
Christine Shen
,
Sanjeev P Bhavnani
,
John D Rogers
Added:
1 year ago
Review Article
Author(s):
Brian Lindman
Added:
10 months ago
ACC 2025 - Primary findings from EARLY-TAVR show the benefit of early TAVR intervention was consistent across biomarker subgroups.Dr Brian Lindman (Vanderbilt University Medical Center, Nashville, US) joins us onsite at ACC 2025 to discuss findings from the primary biomarker analysis from the EARLY TAVR trial (NCT03042104; Edwards Lifesciences). The analysis investigated cardiac biomarkers in…
View more
CPET and Exercise Prescription for Cardiac Rehabilitation
Author(s):
Kaoutar Kabbadj
,
Nora Taiek
,
Wiame El Hjouji
,
et al
Added:
1 year ago
Review Article
Decision-making in the Cardiac ICU
Author(s):
Sarah Godfrey
,
Alexis Barnes
,
Jing Gao
,
et al
Added:
1 year ago
Review Article